NTLA

Intellia Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$13.13

Market Cap

$1.55B

Beta

2.02

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+16.92%

EPS Growth (YoY)+27.05%

Revenue CAGR 3Y+9.09%

P/E Ratio0.0

PEG Ratio—

FCF Yield-25.52%

Debt / Equity0.14

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for NTLA.